Nanomedicine and Veterinary Research Team

Nanomedicine and Veterinary Research Team (NMV) focuses on the research and development of advanced drug delivery systems for the encapsulation, controlled release, and targeted delivery of herbal compounds, pharmaceuticals, and biopharmaceuticals, with the aim of enhancing therapeutic efficacy and improving outcomes in disease prevention and treatment for both human and animal health.

The team conducts research on nanotechnology-based delivery platforms, with particular emphasis on lipid-based and polymeric nanocarriers. The scope of work includes the design, optimization, and characterization of nanocarrier systems, as well as the development of targeted and stimuli-responsive delivery strategies to improve bioavailability, stability, and controlled release of active compounds. These delivery systems are further evaluated through in vitro and in vivo studies to assess pharmacokinetics, efficacy, and safety using relevant experimental and animal models.

The NMV team possesses multidisciplinary expertise spanning nanotechnology, pharmaceutical sciences, biomedical engineering, and veterinary sciences. The team has strong capabilities in nanomaterial fabrication and characterization, surface modification and targeting strategies, and biological evaluation at both cellular and preclinical levels. In addition, the team has experience in translational research, technology readiness level (TRL) advancement, and the development of standardized protocols to support preclinical development and potential industrial applications, ultimately contributing to the development of innovative pharmaceuticals, vaccines, medical supplies, and other health-related products.